1. Home
  2. OVLY vs ZURA Comparison

OVLY vs ZURA Comparison

Compare OVLY & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oak Valley Bancorp (CA)

OVLY

Oak Valley Bancorp (CA)

N/A

Current Price

$30.38

Market Cap

242.9M

Sector

Finance

ML Signal

N/A

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$5.02

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVLY
ZURA
Founded
1990
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.9M
252.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OVLY
ZURA
Price
$30.38
$5.02
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$11.38
AVG Volume (30 Days)
15.6K
467.0K
Earning Date
01-23-2026
11-13-2025
Dividend Yield
1.99%
N/A
EPS Growth
N/A
N/A
EPS
2.84
N/A
Revenue
$79,783,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.58
N/A
Revenue Growth
2.98
N/A
52 Week Low
$22.70
$0.97
52 Week High
$31.45
$5.07

Technical Indicators

Market Signals
Indicator
OVLY
ZURA
Relative Strength Index (RSI) 58.71 76.58
Support Level $30.10 $4.00
Resistance Level $31.45 $4.44
Average True Range (ATR) 0.64 0.28
MACD 0.00 0.08
Stochastic Oscillator 64.76 95.97

Price Performance

Historical Comparison
OVLY
ZURA

About OVLY Oak Valley Bancorp (CA)

Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: